News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

ICON Medical Imaging Enhances Technology Platform to Expedite Oncology Clinical Trials


6/3/2010 10:25:49 AM

DUBLIN--(BUSINESS WIRE)--ICON Medical Imaging, a division of ICON Plc (NASDAQ: ICLR), a global provider of outsourced development services to the pharmaceutical, biotechnology and medical device industries, today announced the enhancement of its ICOSpeedRead™ system to incorporate RECIST 1.1 evaluation criteria.

Read at BioSpace.com


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES